161 related articles for article (PubMed ID: 28242790)
1. Factors Associated with Early Mortality Among Patients with
Vaz-Luis I; Lin NU; Keating NL; Barry WT; Winer EP; Freedman RA
Oncologist; 2017 Apr; 22(4):386-393. PubMed ID: 28242790
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.
Vaz-Luis I; Lin NU; Keating NL; Barry WT; Lii H; Winer EP; Freedman RA
Breast Cancer Res Treat; 2015 Jun; 151(3):697-707. PubMed ID: 26022349
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic factors associated with de novo metastatic breast cancer.
Shen T; Siegal GP; Wei S
Pathol Res Pract; 2016 Dec; 212(12):1167-1173. PubMed ID: 27692496
[TBL] [Abstract][Full Text] [Related]
5. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.
Zeichner SB; Herna S; Mani A; Ambros T; Montero AJ; Mahtani RL; Ahn ER; Vogel CL
Breast Cancer Res Treat; 2015 Oct; 153(3):617-24. PubMed ID: 26358708
[TBL] [Abstract][Full Text] [Related]
7. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
Ayanian JZ; Kohler BA; Abe T; Epstein AM
N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer.
Han Y; Langston M; Fuzzell L; Khan S; Lewis-Thames MW; Colditz GA; Moore JX
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442659
[TBL] [Abstract][Full Text] [Related]
9. The effect of delays in treatment for breast cancer metastasis on survival.
Jung SY; Sereika SM; Linkov F; Brufsky A; Weissfeld JL; Rosenzweig M
Breast Cancer Res Treat; 2011 Dec; 130(3):953-64. PubMed ID: 21739101
[TBL] [Abstract][Full Text] [Related]
10. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
11. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center.
O'Connor TL; Ngamphaiboon N; Groman A; Luczkiewicz DL; Kuszczak SM; Grant PC; Kerr CW
J Palliat Med; 2015 Jan; 18(1):50-5. PubMed ID: 25353618
[TBL] [Abstract][Full Text] [Related]
12. Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
Bertaut A; Mounier M; Desmoulins I; Guiu S; Beltjens F; Darut-Jouve A; Ponnelle T; Arnould L; Arveux P
Eur J Cancer Care (Engl); 2015 Nov; 24(6):920-8. PubMed ID: 25757548
[TBL] [Abstract][Full Text] [Related]
13. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
14. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.
Ording AG; Heide-Jørgensen U; Christiansen CF; Nørgaard M; Acquavella J; Sørensen HT
Clin Exp Metastasis; 2017 Jan; 34(1):93-101. PubMed ID: 27718076
[TBL] [Abstract][Full Text] [Related]
15. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis.
Leone BA; Vallejo CT; Romero AO; Machiavelli MR; Pérez JE; Leone J; Leone JP
Breast Cancer Res Treat; 2017 Feb; 161(3):537-548. PubMed ID: 27975154
[TBL] [Abstract][Full Text] [Related]
17. Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2(-) metastatic breast cancer.
Engel-Nitz NM; Hao Y; Becker LK; Gerdes R
J Comp Eff Res; 2015 Aug; 4(4):303-14. PubMed ID: 26274792
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics.
Colzani E; Liljegren A; Johansson AL; Adolfsson J; Hellborg H; Hall PF; Czene K
J Clin Oncol; 2011 Oct; 29(30):4014-21. PubMed ID: 21911717
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC
BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with metastatic breast cancer at the time of diagnosis.
Ren Z; Li Y; Hameed O; Siegal GP; Wei S
Pathol Res Pract; 2014 May; 210(5):301-6. PubMed ID: 24635972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
